
Newsletter
Promoter: | Vip Penny Stocks | Paying Party: | UNKNOWN |
Stocks covered: | Compensation: | Avg $ Volume for Period: |
ACOL | $3000 | 3260 |
Max Profit: 14.29 % | Gain at close: -21.43 % | |
*We think that this promoter is a part of a group of promoters. |

Hello Valued VIP Subscribers
After November sales exceeded expectations, ACOL essentially experienced product shortages. ACOL is bullish on 2015 futures and sees the potential for strong earnings in the 1st Quarter.
This is a problem that many companies would love to have... so let’s look deeper to how and why ACOL’s product is becoming so popular. ACOL’s groundbreaking, patented product in the booming MJ market is known as the Medtainer:
- The Medtainer was nominated for the award of MJ “Product of the Year” and was sponsored by High Times Magazine at the 25th Annual Cannabis Cup in Amsterdam.
- The Company’s flagship product, the MedTainer was selected to be part of and placed in the Celebrity Bag Giveaway at this year’s American Music Awards.
- ACOL’s products are already found in more than 100 stores across the U.S.
- The Medtainer has recently been featured in major publications including Cannabis Now, Green Leaf, High Times and even the Weed Street Journal.
- Celebrities like Asher Roth and B-Real from Cypress Hill have been seen using the Medtainer product.
- GreenWave Advisors forecast that 37 states will pass MJ for medical purposes by 2020 and a dozen states will pass it for recreational use.
- Enormous growth of this market is also reflected in ACOL’s product sales: for the 6-month period ending June 30, 2014, the Company reported a Net Sales increase of 87%.
ACOL has a widely used and widely needed product in a booming market. It’s received high reviews, considerable accolades and an amazing level of pliability. As it’s slipped recently a bounce could translate to a big move, so let’s get to it:
Acology Inc. (ACOL)
The Medtainer Website :: Acology website :: ACOL Quote
According to Acology, “Acology is bullish on 2015 futures and sees the potential for strong earnings in the 1st quarter.”
The Company’s 4th generation Medtainer is a patented, FDA approved #5 polypropylene container that is water-proof, smell-proof and child resistant. Its most impressive feature is a built-in grinder that has the ability to grinds pills, herbal medications, coffee beans and teas into fine powder.
ACOL also markets the Medtainer to the exploding MJ market, making it one of the hottest new MJ products around right now. It was nominated for product of the year by High Times, which is perhaps the biggest name in all of MJ.
The Company’s products can be found in more than 100 stores across the US and is beginning to receive a lot of attention, with the Medtainer being featured in major cannabis publications including 1000Watts, Nuggetry Magazine, Cannabis Now, Green Leaf, Hot Breath, HotBox Magazine, Cannabis Culture Magazine, and even the Weed Street Journal.
ACOL seems to be heavily in an all-out marketing mode right now as it is strategically building its advisory board with quality, well known industry professionals as well as respected professionals within the industries of which ACOL sees sales potential.
Recent news is a perfect example as ACOL announced the addition of the co-founder of the “Unconventional Foundation for Autism” to its team.
To keep up with demand ACOL has found it necessary to increase their manufacturing capabilities. As orders continue to surge the possibility of production shortfalls has forced ACOL to consider acquiring additional manufacturing equipment to deal with the increasing demand.
Do I have your attention yet?
Tonight’s play could be the whole package. From product to company to market… ACOL has a lot going their way right now.
The recent elections saw Oregon, Alaska and Washington D.C. all pass their initiatives in favor of MJ. I’m sure you remember the market boom when Colorado & Washington voted to pass recreational MJ. Some MJ companies saw enormous gains the likes of which are rarely seen.
In fact, I recently read this article that was released by Forbes: Why Legalizing Medical Marijuana Will Make Investors Extremely Wealthy
With the MJ market expected to grow 64% to 2.34Bln in 2014 up from 1.44Bln the previous year, the potential for professional companies to help legitimize the industry and to draw profits from it appears to be on the horizon.
The Medtainer:
The Medtainer is the first-ever polypropylene airtight, watertight, smell-proof delivery and storage container that has a built in grinder. Take a look at the Product on the Company’s website:
http://themedtainer.myshopify.com/collections
The Medtainer is manufactured from medical-grade No. 5 polypropylene resin that is non-porous and non-leaching. The Medtainer is composed of FDA approved medical grade plastics and is environmentally safe.
These containers are portable and affordable and give consumers the ability to easily store, carry and grind herbs and herbal remedies, teas, medicines, and other solids or liquids without cross-contamination or leakage.
Target markets include Private & Compounding Pharmacies, Oriental and Traditional Herbal Pharmacists, and Veterinary Clinicians. The following quote discussing future growth was taken straight out of their press release:
“Acology marketing and sales efforts are now focusing on these markets and increasing revenue is expected as distribution climbs in 2014.”
For the six-month period ending June 30, 2014, ACOL reported a Net Sales increase of 87%, or $168k as compared to $90k for the six-month period ended June 30, 2013.
Recent Developments:
ACOL recently completed its new headquarters and manufacturing facility located in Corona, CA. Key benefits include the expanded manufacturing capabilities and shipping areas, allowing for increased volume and efficiency.
ACOL entered an agreement with Specialty Pharmacy, a dispensing chemists compounding pharmacy, to provide the Medtainer for its customers.
The Company has also announced they are in serious talks with Altura Pharmaceuticals to provide the Medtainer to Altura's pharmacies in all 8 states that it has a presence in. Primo Cabral, the President of Altura Pharmaceuticals, stated:
"We found the Medtainer extremely effective in reducing pills, and especially hard pills, to a fine powder in just a matter of seconds. This reduces the need to use more traditional methods, such as a mortar and pestle, saving time and energy."
Conclusion:
ACOL has a very unique and patented product that is servicing the MedMJ market and even has several celebrities already using it in public. As the Medtainer gains traction and more and more celebs are seen with it, ACOL should continue its rise to fame.
As I stated earlier, tonight’s play could be the “Real Deal”. From product - to company - to market… ACOL has a lot going there way right now.
We could be looking at a one-of-a-kind situation unfolding right before our very eyes.
Before we finish up I’m going to take a quick look at a few of the Green Indicators on ACOL:
Short Term
Exponential Moving Average: Very Bullish
Moving Average Convergence/Divergence: Very Bullish
Stochastic: Very Bullish
Medium Term
Exponential Moving Average: Bullish
Moving Average Convergence/Divergence: Bullish
Three-Day Displaced Moving Average: Bullish
Not to mention the Stochastic is “Very Bullish” as we speak!
With groundbreaking legislation opening newer and untouched markets, ACOL could be in the right place at the right time.
Get started on researching ACOL right away.
As always, we encourage you to do further research. Also, when you find yourself in a position to profit, it is often wise to do so.Remember, we always encourage you to do further research. Never take our word for it, read our disclaimer to see why, and of course always consult a professional.
Just because a situation looks great things can still go wrong and often do. Be smart and protect yourself.
Be back with you soon,
Remember to insure timely delivery please add our email (info@vippennystocksite.com) to your safe senders contacts. We would hate for you to not receive the alert on time or not at all.
PLEASE NOTE WELL: Vippennystocksite.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. VIPPENNYSTOCKSITE.COM WILL NEVER ACCEPT FREE OR RESTRICTED TRADING SHARES IN ANY COMPANIES MENTIONED at VIPPENNYSTOCKSITE.COM &/OR ANY OF OUR SOCIAL NETWORKING AND EMAIL ADVERTISING PLATFORMS.
*Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.*
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The paying party may own shares and may liquidate them during the promotional period.
You are reading this newsletter because you have subscribed via our Opt-In Signup form on our Website. If you have been subscribed by mistake, you may unsubscribe at any time.
We been compensated up to 3.thousand cash dollars via bank wire from and un-affiliated 3rd party for this profile of ACOL.
Releaseof Liability: Through use of this email and/or website advertisement viewing or using you agree to hold Vippennystocksite.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. Vippennystocksite.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Vippennystocksite.com or an offer or solicitation to buy or sell any security.
The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Vippennystocksite.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Vippennystocksite.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Further, Vippennystocksite.com has no advance knowledge of any future events of the profiled companies which includes, but is not limited to, news & press releases, changes in corporate structure, or changes in share structure.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Vippennystocksite.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. Vippennystocksite.com is compliant with the Can Spam Act of 2003. Vippennystocksite.com does not offer such advice or analysis, and Vippennystocksite.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security's previous day closing price and the high of day price during our promotional coverage.
In preparing this publication, Vippennystocksite.com has relied upon information supplied by various public sources and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this email and website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this email and website are believed to be reliable, however, Vippennystocksite.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Vippennystocksite.com is not responsible for any claims made by the companies advertised herein, nor is Vippennystocksite.com responsible for any other promotional firm, its program or its structure.
This message was sent to xxxxxx@gmail.com from: VIP PS | info@vippennystocksite.com | Eden Media Group LLC | PO BOX 3657 | Half Moon Bay, California 94019 |
Email Marketing by |